Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2000 Aug;108(8):701–708. doi: 10.1289/ehp.00108701

Genistein: does it prevent or promote breast cancer?

K B Bouker 1, L Hilakivi-Clarke 1
PMCID: PMC1638285  PMID: 10964789

Abstract

Diet is estimated to contribute to approximately 50% of all newly diagnosed breast cancers. As such, a search for dietary factors differentially consumed among populations with increased breast cancer risk (e.g., Caucasians) compared to those with low risk (e.g., Asians) has become a priority. One such dietary component, which is typical to the Asian but not the Caucasian diet, is soy. We review data relevant to attempts to determine whether soy, and more specifically genistein, is a dietary component that may help to explain the dramatic disparity in breast cancer risk among these populations.

Full text

PDF
701

Images in this article

703Figure 1
on p.703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. 3rd International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. Washington DC, USA. October 31-November 3, 1999. Proceedings and abstracts. J Nutr. 2000 Mar;130(3):653S–711S. doi: 10.1093/jn/130.3.653S. [DOI] [PubMed] [Google Scholar]
  2. Adlercreutz H. Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothesis. Proc Soc Exp Biol Med. 1998 Mar;217(3):241–246. doi: 10.3181/00379727-217-44228. [DOI] [PubMed] [Google Scholar]
  3. Adlercreutz H., Yamada T., Wähälä K., Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol. 1999 Mar;180(3 Pt 1):737–743. doi: 10.1016/s0002-9378(99)70281-4. [DOI] [PubMed] [Google Scholar]
  4. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987 Apr 25;262(12):5592–5595. [PubMed] [Google Scholar]
  5. Anderson J. J., Ambrose W. W., Garner S. C. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med. 1998 Mar;217(3):345–350. doi: 10.3181/00379727-217-44243. [DOI] [PubMed] [Google Scholar]
  6. Baird D. D., Umbach D. M., Lansdell L., Hughes C. L., Setchell K. D., Weinberg C. R., Haney A. F., Wilcox A. J., Mclachlan J. A. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab. 1995 May;80(5):1685–1690. doi: 10.1210/jcem.80.5.7745019. [DOI] [PubMed] [Google Scholar]
  7. Baker M. E., Medlock K. L., Sheehan D. M. Flavonoids inhibit estrogen binding to rat alpha-fetoprotein. Proc Soc Exp Biol Med. 1998 Mar;217(3):317–321. doi: 10.3181/00379727-217-44238. [DOI] [PubMed] [Google Scholar]
  8. Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat. 1997 Nov-Dec;46(2-3):169–179. doi: 10.1023/a:1005956326155. [DOI] [PubMed] [Google Scholar]
  9. Brown N. M., Wang J., Cotroneo M. S., Zhao Y. X., Lamartiniere C. A. Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol. 1998 Sep 25;144(1-2):149–165. doi: 10.1016/s0303-7207(98)00106-3. [DOI] [PubMed] [Google Scholar]
  10. Cassidy A., Bingham S., Setchell K. D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994 Sep;60(3):333–340. doi: 10.1093/ajcn/60.3.333. [DOI] [PubMed] [Google Scholar]
  11. Cassidy A., Bingham S., Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr. 1995 Oct;74(4):587–601. doi: 10.1079/bjn19950160. [DOI] [PubMed] [Google Scholar]
  12. Chrysogelos S. A., Dickson R. B. EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat. 1994 Jan;29(1):29–40. doi: 10.1007/BF00666179. [DOI] [PubMed] [Google Scholar]
  13. Connolly J. M., Liu X. H., Rose D. P. Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. Nutr Cancer. 1997;29(1):48–54. doi: 10.1080/01635589709514601. [DOI] [PubMed] [Google Scholar]
  14. Dickson R. B., Lippman M. E. Growth factors in breast cancer. Endocr Rev. 1995 Oct;16(5):559–589. doi: 10.1210/edrv-16-5-559. [DOI] [PubMed] [Google Scholar]
  15. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res. 1992 Apr 1;52(7 Suppl):2024s–2029s. [PubMed] [Google Scholar]
  16. Duncan A. M., Merz B. E., Xu X., Nagel T. C., Phipps W. R., Kurzer M. S. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999 Jan;84(1):192–197. doi: 10.1210/jcem.84.1.5387. [DOI] [PubMed] [Google Scholar]
  17. Dunn J. E. Cancer epidemiology in populations of the United States--with emphasis on Hawaii and California--and Japan. Cancer Res. 1975 Nov;35(11 Pt 2):3240–3245. [PubMed] [Google Scholar]
  18. Ekbom A., Hsieh C. C., Lipworth L., Adami H. Q., Trichopoulos D. Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst. 1997 Jan 1;89(1):71–76. doi: 10.1093/jnci/89.1.71. [DOI] [PubMed] [Google Scholar]
  19. Folman Y., Pope G. S. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol. 1966 Feb;34(2):215–225. doi: 10.1677/joe.0.0340215. [DOI] [PubMed] [Google Scholar]
  20. Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2690–2694. doi: 10.1073/pnas.90.7.2690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fritz W. A., Coward L., Wang J., Lamartiniere C. A. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis. 1998 Dec;19(12):2151–2158. doi: 10.1093/carcin/19.12.2151. [DOI] [PubMed] [Google Scholar]
  22. Gann P., Chatterton R., Vogelsong K., Dupuis J., Ellman A. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability. Cancer Epidemiol Biomarkers Prev. 1997 Jun;6(6):421–428. [PubMed] [Google Scholar]
  23. Goldin B. R., Adlercreutz H., Gorbach S. L., Woods M. N., Dwyer J. T., Conlon T., Bohn E., Gershoff S. N. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr. 1986 Dec;44(6):945–953. doi: 10.1093/ajcn/44.6.945. [DOI] [PubMed] [Google Scholar]
  24. Gotoh T., Yamada K., Yin H., Ito A., Kataoka T., Dohi K. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res. 1998 Feb;89(2):137–142. doi: 10.1111/j.1349-7006.1998.tb00541.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Grubbs C. J., Farnell D. R., Hill D. L., McDonough K. C. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J Natl Cancer Inst. 1985 Apr;74(4):927–931. [PubMed] [Google Scholar]
  26. Hawrylewicz E. J., Huang H. H., Blair W. H. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr. 1991 Oct;121(10):1693–1698. doi: 10.1093/jn/121.10.1693. [DOI] [PubMed] [Google Scholar]
  27. Hilakivi-Clarke L., Cho E., Clarke R. Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Oncol Rep. 1998 May-Jun;5(3):609–616. doi: 10.3892/or.5.3.609. [DOI] [PubMed] [Google Scholar]
  28. Hilakivi-Clarke L., Cho E., Onojafe I., Raygada M., Clarke R. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep. 1999 Sep-Oct;6(5):1089–1095. doi: 10.3892/or.6.5.1089. [DOI] [PubMed] [Google Scholar]
  29. Hilakivi-Clarke L., Clarke R. Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity. Mol Cell Biochem. 1998 Nov;188(1-2):5–12. [PubMed] [Google Scholar]
  30. Hilakivi-Clarke L., Onojafe I., Raygada M., Cho E., Skaar T., Russo I., Clarke R. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer. 1999 Aug;80(11):1682–1688. doi: 10.1038/sj.bjc.6690584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hirohata T., Shigematsu T., Nomura A. M., Nomura Y., Horie A., Hirohata I. Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr. 1985 Dec;69:187–190. [PubMed] [Google Scholar]
  32. Hsieh C. Y., Santell R. C., Haslam S. Z., Helferich W. G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998 Sep 1;58(17):3833–3838. [PubMed] [Google Scholar]
  33. Huckell C., Laskin J., Gelmon K. Premenopausal breast cancer after in-utero exposure to stilboestrol. Lancet. 1996 Aug 3;348(9023):331–331. doi: 10.1016/s0140-6736(96)24031-0. [DOI] [PubMed] [Google Scholar]
  34. Hughes C. L., Jr, Kaldas R. S., Weisinger A. S., McCants C. E., Basham K. B. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomized rat: Part 1. Reprod Toxicol. 1991;5(2):127–132. doi: 10.1016/0890-6238(91)90040-m. [DOI] [PubMed] [Google Scholar]
  35. Hulka B. S., Stark A. T. Breast cancer: cause and prevention. Lancet. 1995 Sep 30;346(8979):883–887. doi: 10.1016/s0140-6736(95)92713-1. [DOI] [PubMed] [Google Scholar]
  36. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 1997 Oct 4;350(9083):990–994. doi: 10.1016/S0140-6736(97)01339-1. [DOI] [PubMed] [Google Scholar]
  37. Ishimi Y., Miyaura C., Ohmura M., Onoe Y., Sato T., Uchiyama Y., Ito M., Wang X., Suda T., Ikegami S. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology. 1999 Apr;140(4):1893–1900. doi: 10.1210/endo.140.4.6663. [DOI] [PubMed] [Google Scholar]
  38. Jordan V. C. Tamoxifen treatment for breast cancer: concept to gold standard. Oncology (Williston Park) 1997 Feb;11(2 Suppl 1):7–13. [PubMed] [Google Scholar]
  39. Kaufmann W. K. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc Soc Exp Biol Med. 1998 Mar;217(3):327–334. doi: 10.3181/00379727-217-44240. [DOI] [PubMed] [Google Scholar]
  40. Key T. J., Chen J., Wang D. Y., Pike M. C., Boreham J. Sex hormones in women in rural China and in Britain. Br J Cancer. 1990 Oct;62(4):631–636. doi: 10.1038/bjc.1990.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kim H., Peterson T. G., Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1418S–1425S. doi: 10.1093/ajcn/68.6.1418S. [DOI] [PubMed] [Google Scholar]
  42. Koroma B. M., de Juan E., Jr Inhibition of protein tyrosine phosphorylation in endothelial cells: relationship to antiproliferative action of genistein. Biochem Soc Trans. 1997 Feb;25(1):35–40. doi: 10.1042/bst0250035. [DOI] [PubMed] [Google Scholar]
  43. Kreiger N., Sloan M., Cotterchio M., Kirsh V. The risk of breast cancer following reproductive surgery. Eur J Cancer. 1999 Jan;35(1):97–101. doi: 10.1016/s0959-8049(98)00343-8. [DOI] [PubMed] [Google Scholar]
  44. Kuiper G. G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997 Mar;138(3):863–870. doi: 10.1210/endo.138.3.4979. [DOI] [PubMed] [Google Scholar]
  45. Lamartiniere C. A., Moore J. B., Brown N. M., Thompson R., Hardin M. J., Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis. 1995 Nov;16(11):2833–2840. doi: 10.1093/carcin/16.11.2833. [DOI] [PubMed] [Google Scholar]
  46. Lamartiniere C. A., Murrill W. B., Manzolillo P. A., Zhang J. X., Barnes S., Zhang X., Wei H., Brown N. M. Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med. 1998 Mar;217(3):358–364. doi: 10.3181/00379727-217-44245. [DOI] [PubMed] [Google Scholar]
  47. Le Marchand L., Kolonel L. N., Earle M. E., Mi M. P. Body size at different periods of life and breast cancer risk. Am J Epidemiol. 1988 Jul;128(1):137–152. doi: 10.1093/oxfordjournals.aje.a114936. [DOI] [PubMed] [Google Scholar]
  48. Lee H. P., Gourley L., Duffy S. W., Estéve J., Lee J., Day N. E. Dietary effects on breast-cancer risk in Singapore. Lancet. 1991 May 18;337(8751):1197–1200. doi: 10.1016/0140-6736(91)92867-2. [DOI] [PubMed] [Google Scholar]
  49. Leopold A. S., Erwin M., Oh J., Browning B. Phytoestrogens: adverse effects on reproduction in California quail. Science. 1976 Jan 9;191(4222):98–100. doi: 10.1126/science.1246602. [DOI] [PubMed] [Google Scholar]
  50. Li Y., Bhuiyan M., Sarkar F. H. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. Int J Oncol. 1999 Sep;15(3):525–533. doi: 10.3892/ijo.15.3.525. [DOI] [PubMed] [Google Scholar]
  51. Lopez J., Ogren L., Verjan R., Talamantes F. Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice. Teratology. 1988 Aug;38(2):129–134. doi: 10.1002/tera.1420380205. [DOI] [PubMed] [Google Scholar]
  52. Loukovaara M., Carson M., Palotie A., Adlercreutz H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids. 1995 Sep;60(9):656–661. doi: 10.1016/0039-128x(95)00089-9. [DOI] [PubMed] [Google Scholar]
  53. Lu L. J., Anderson K. E., Grady J. J., Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):63–70. [PubMed] [Google Scholar]
  54. Magnusson C., Baron J., Persson I., Wolk A., Bergström R., Trichopoulos D., Adami H. O. Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer. 1998 Mar 30;76(1):29–34. doi: 10.1002/(sici)1097-0215(19980330)76:1<29::aid-ijc6>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  55. Martin P. M., Horwitz K. B., Ryan D. S., McGuire W. L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978 Nov;103(5):1860–1867. doi: 10.1210/endo-103-5-1860. [DOI] [PubMed] [Google Scholar]
  56. Martinez-Campos A., Amara J. F., Dannies P. S. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures. Mol Cell Endocrinol. 1986 Dec;48(2-3):127–133. doi: 10.1016/0303-7207(86)90035-3. [DOI] [PubMed] [Google Scholar]
  57. Matsukawa Y., Marui N., Sakai T., Satomi Y., Yoshida M., Matsumoto K., Nishino H., Aoike A. Genistein arrests cell cycle progression at G2-M. Cancer Res. 1993 Mar 15;53(6):1328–1331. [PubMed] [Google Scholar]
  58. McMichael-Phillips D. F., Harding C., Morton M., Roberts S. A., Howell A., Potten C. S., Bundred N. J. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1431S–1435S. doi: 10.1093/ajcn/68.6.1431S. [DOI] [PubMed] [Google Scholar]
  59. Messina M. J., Persky V., Setchell K. D., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer. 1994;21(2):113–131. doi: 10.1080/01635589409514310. [DOI] [PubMed] [Google Scholar]
  60. Miettinen M. M., Mustonen M. V., Poutanen M. H., Isomaa V. V., Vihko R. K. Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. Biochem J. 1996 Mar 15;314(Pt 3):839–845. doi: 10.1042/bj3140839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Mueller S. C., Yeh Y., Chen W. T. Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J Cell Biol. 1992 Dec;119(5):1309–1325. doi: 10.1083/jcb.119.5.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Murrill W. B., Brown N. M., Zhang J. X., Manzolillo P. A., Barnes S., Lamartiniere C. A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis. 1996 Jul;17(7):1451–1457. doi: 10.1093/carcin/17.7.1451. [DOI] [PubMed] [Google Scholar]
  63. Mäkelä S., Poutanen M., Kostian M. L., Lehtimäki N., Strauss L., Santti R., Vihko R. Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med. 1998 Mar;217(3):310–316. doi: 10.3181/00379727-217-44237. [DOI] [PubMed] [Google Scholar]
  64. Mäkelä S., Savolainen H., Aavik E., Myllärniemi M., Strauss L., Taskinen E., Gustafsson J. A., Häyry P. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7077–7082. doi: 10.1073/pnas.96.12.7077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Nagasawa H., Yanai R., Shodono M., Nakamura T., Tanabe Y. Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17 beta level in rats. Cancer Res. 1974 Oct;34(10):2643–2646. [PubMed] [Google Scholar]
  66. Nagata C., Takatsuka N., Inaba S., Kawakami N., Shimizu H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst. 1998 Dec 2;90(23):1830–1835. doi: 10.1093/jnci/90.23.1830. [DOI] [PubMed] [Google Scholar]
  67. Nagel S. C., vom Saal F. S., Welshons W. V. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med. 1998 Mar;217(3):300–309. doi: 10.3181/00379727-217-44236. [DOI] [PubMed] [Google Scholar]
  68. Paech K., Webb P., Kuiper G. G., Nilsson S., Gustafsson J., Kushner P. J., Scanlan T. S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997 Sep 5;277(5331):1508–1510. doi: 10.1126/science.277.5331.1508. [DOI] [PubMed] [Google Scholar]
  69. Peterson G., Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 1996 Oct;7(10):1345–1351. [PubMed] [Google Scholar]
  70. Peterson G., Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 1996 Oct;7(10):1345–1351. [PubMed] [Google Scholar]
  71. Petrakis N. L., Barnes S., King E. B., Lowenstein J., Wiencke J., Lee M. M., Miike R., Kirk M., Coward L. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):785–794. [PubMed] [Google Scholar]
  72. Petrakis N. L., King E. B., Lee M., Miike R. Cerumen phenotype and proliferative epithelium in breast fluids of U.S.-born vs. immigrant Asian women: a possible genetic-environmental interaction. Breast Cancer Res Treat. 1990 Oct;16(3):279–285. doi: 10.1007/BF01806336. [DOI] [PubMed] [Google Scholar]
  73. Poutanen M., Isomaa V., Peltoketo H., Vihko R. Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis. J Steroid Biochem Mol Biol. 1995 Dec;55(5-6):525–532. doi: 10.1016/0960-0760(95)00201-4. [DOI] [PubMed] [Google Scholar]
  74. Santell R. C., Chang Y. C., Nair M. G., Helferich W. G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr. 1997 Feb;127(2):263–269. doi: 10.1093/jn/127.2.263. [DOI] [PubMed] [Google Scholar]
  75. Santibáez J. F., Navarro A., Martínez J. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res. 1997 Mar-Apr;17(2A):1199–1204. [PubMed] [Google Scholar]
  76. Schultze-Mosgau M. H., Dale I. L., Gant T. W., Chipman J. K., Kerr D. J., Gescher A. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. Eur J Cancer. 1998 Aug;34(9):1425–1431. doi: 10.1016/s0959-8049(98)00223-8. [DOI] [PubMed] [Google Scholar]
  77. Shao Z. M., Wu J., Shen Z. Z., Barsky S. H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 1998 Nov 1;58(21):4851–4857. [PubMed] [Google Scholar]
  78. Shertzer H. G., Puga A., Chang C., Smith P., Nebert D. W., Setchell K. D., Dalton T. P. Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones. Chem Biol Interact. 1999 Nov 15;123(1):31–49. doi: 10.1016/s0009-2797(99)00121-0. [DOI] [PubMed] [Google Scholar]
  79. Shimizu H., Ross R. K., Bernstein L., Yatani R., Henderson B. E., Mack T. M. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 1991 Jun;63(6):963–966. doi: 10.1038/bjc.1991.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Shutt D. A., Cox R. I. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol. 1972 Feb;52(2):299–310. doi: 10.1677/joe.0.0520299. [DOI] [PubMed] [Google Scholar]
  81. Thomas D. B., Karagas M. R. Cancer in first and second generation Americans. Cancer Res. 1987 Nov 1;47(21):5771–5776. [PubMed] [Google Scholar]
  82. Tikkanen M. J., Wähälä K., Ojala S., Vihma V., Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3106–3110. doi: 10.1073/pnas.95.6.3106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Toniolo P. G., Levitz M., Zeleniuch-Jacquotte A., Banerjee S., Koenig K. L., Shore R. E., Strax P., Pasternack B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995 Feb 1;87(3):190–197. doi: 10.1093/jnci/87.3.190. [DOI] [PubMed] [Google Scholar]
  84. Uckun F. M., Evans W. E., Forsyth C. J., Waddick K. G., Ahlgren L. T., Chelstrom L. M., Burkhardt A., Bolen J., Myers D. E. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science. 1995 Feb 10;267(5199):886–891. doi: 10.1126/science.7531365. [DOI] [PubMed] [Google Scholar]
  85. Uckun F. M., Narla R. K., Jun X., Zeren T., Venkatachalam T., Waddick K. G., Rostostev A., Myers D. E. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells. Clin Cancer Res. 1998 Apr;4(4):901–912. [PubMed] [Google Scholar]
  86. Wang C., Mäkelä T., Hase T., Adlercreutz H., Kurzer M. S. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):205–212. doi: 10.1016/0960-0760(94)90030-2. [DOI] [PubMed] [Google Scholar]
  87. Wang T. T., Sathyamoorthy N., Phang J. M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 1996 Feb;17(2):271–275. doi: 10.1093/carcin/17.2.271. [DOI] [PubMed] [Google Scholar]
  88. Wilcox J. N., Blumenthal B. F. Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. J Nutr. 1995 Mar;125(3 Suppl):631S–638S. doi: 10.1093/jn/125.suppl_3.631S. [DOI] [PubMed] [Google Scholar]
  89. Willett W. C. Diet, nutrition, and avoidable cancer. Environ Health Perspect. 1995 Nov;103 (Suppl 8):165–170. doi: 10.1289/ehp.95103s8165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Witte J. S., Ursin G., Siemiatycki J., Thompson W. D., Paganini-Hill A., Haile R. W. Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat. 1997 Feb;42(3):243–251. doi: 10.1023/a:1005710211184. [DOI] [PubMed] [Google Scholar]
  91. Wrensch M. R., Petrakis N. L., Gruenke L. D., Ernster V. L., Miike R., King E. B., Hauck W. W. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat. 1990 Jan;15(1):39–51. doi: 10.1007/BF01811888. [DOI] [PubMed] [Google Scholar]
  92. Wu A. H., Ziegler R. G., Horn-Ross P. L., Nomura A. M., West D. W., Kolonel L. N., Rosenthal J. F., Hoover R. N., Pike M. C. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):901–906. [PubMed] [Google Scholar]
  93. Wu A. H., Ziegler R. G., Nomura A. M., West D. W., Kolonel L. N., Horn-Ross P. L., Hoover R. N., Pike M. C. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1437S–1443S. doi: 10.1093/ajcn/68.6.1437S. [DOI] [PubMed] [Google Scholar]
  94. Xu X., Duncan A. M., Merz B. E., Kurzer M. S. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1101–1108. [PubMed] [Google Scholar]
  95. Yuan J. M., Wang Q. S., Ross R. K., Henderson B. E., Yu M. C. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer. 1995 Jun;71(6):1353–1358. doi: 10.1038/bjc.1995.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Zava D. T., Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27(1):31–40. doi: 10.1080/01635589709514498. [DOI] [PubMed] [Google Scholar]
  97. Zheng W., Dai Q., Custer L. J., Shu X. O., Wen W. Q., Jin F., Franke A. A. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):35–40. [PubMed] [Google Scholar]
  98. Ziegler R. G., Hoover R. N., Pike M. C., Hildesheim A., Nomura A. M., West D. W., Wu-Williams A. H., Kolonel L. N., Horn-Ross P. L., Rosenthal J. F. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993 Nov 17;85(22):1819–1827. doi: 10.1093/jnci/85.22.1819. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES